A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

2006 ◽  
Vol 44 (4) ◽  
pp. 671-678 ◽  
Author(s):  
Vincent G. Bain ◽  
Kelly D. Kaita ◽  
Eric M. Yoshida ◽  
Mark G. Swain ◽  
E. Jenny Heathcote ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document